Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A

Updated on: January 15,2024

Novel T cell receptor therapy shows early anti-tumor activity

byUniversity of Texas M. D. Anderson Cancer CenterCredit: CC0 Public DomainAfamitresgene autoleucel (afami-cel; formerly ADP-A2M4), an adoptive T cell receptor (TCR) therapy targeting the MAGE-A

Updated on:January 15,2024

Study unveils the engagement of different cortical networks while humans are unconscious

by Ingrid Fadelli , Medical XpressCredit:Neuron(2023). DOI: 10.1016/j.neuron.2023.08.007States of unconsciousness, such as those that occur during sleep or while under the effect of anesth

Updated on: July 02,2024

Study unveils the engagement of different cortical networks while humans are unconscious

by Ingrid Fadelli , Medical XpressCredit:Neuron(2023). DOI: 10.1016/j.neuron.2023.08.007States of unconsciousness, such as those that occur during sleep or while under the effect of anesth

Updated on:July 02,2024

New therapy proposed to treat 'axillary web syndrome' in women who have had a mastectomy

by University of MalagaNew therapy proposed to treat "axillary web syndrome" in women who have had a mastectomy. Credit: University of MalagaAxillary web syndrome, also known as lymphatic th

Updated on: January 15,2024

New therapy proposed to treat 'axillary web syndrome' in women who have had a mastectomy

by University of MalagaNew therapy proposed to treat "axillary web syndrome" in women who have had a mastectomy. Credit: University of MalagaAxillary web syndrome, also known as lymphatic th

Updated on:January 15,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on: March 30,2024

Atezolizumab + bevacizumab shows benefit in met renal CA

(HealthDay)—For patients with metastatic renal cell carcinoma (mRCC), atezolizumab plus bevacizumab is associated with a progression-free survival benefit versus sunitinib, according to a study presen

Updated on:March 30,2024

Study: 'GPS' seed devices effective in localizing breast tumors

by Tim Tedeschi,University of CincinnatiCredit: Pixabay/CC0 Public DomainUniversity of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remo

Updated on: March 06,2024

Study: 'GPS' seed devices effective in localizing breast tumors

by Tim Tedeschi,University of CincinnatiCredit: Pixabay/CC0 Public DomainUniversity of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remo

Updated on:March 06,2024

Assay to ID anticancer reagents targeting fructose-1,6-bisphosphate aldolase

by SLAS (Society for Laboratory Automation and Screening)ALDOA catalyzes the reversible aldol cleavage of fructose-1,6-bisphosphate (F-1,6-BP) into D-Glyceraldehyde-3-phosphate (GAP) and dihydroxyacet

Updated on: March 01,2024

Assay to ID anticancer reagents targeting fructose-1,6-bisphosphate aldolase

by SLAS (Society for Laboratory Automation and Screening)ALDOA catalyzes the reversible aldol cleavage of fructose-1,6-bisphosphate (F-1,6-BP) into D-Glyceraldehyde-3-phosphate (GAP) and dihydroxyacet

Updated on:March 01,2024

Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

by European Organisation for Research and Treatment of CancerThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Ima

Updated on: March 30,2024

Low-dose radiotherapy boost helps prevent local recurrence with better cosmetic outcomes in young breast cancer patients

by European Organisation for Research and Treatment of CancerThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Ima

Updated on:March 30,2024

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on: February 03,2024

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Updated on:February 03,2024

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress

Updated on: January 23,2024

Adding pembrolizumab to chemo improves survival in cervical cancer, finds study

by Elana GotkineFor women with persistent, recurrent, or metastatic cervical cancer, adding pembrolizumab to chemotherapy, with or without bevacizumab, is associated with improved overall and progress

Updated on:January 23,2024

An unexpected developmental hierarchy in an unusual disease

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesLCH cells from a tumour biopsy, imaged with a confocal microscope. The green staining identifies the actively prolifer

Updated on: April 20,2024

An unexpected developmental hierarchy in an unusual disease

by CeMM Research Center for Molecular Medicine of the Austrian Academy of SciencesLCH cells from a tumour biopsy, imaged with a confocal microscope. The green staining identifies the actively prolifer

Updated on:April 20,2024

Having more babies lowers the risk of endometrial cancer, study finds

by Institute for Molecular BioscienceCredit: Unsplash/CC0 Public DomainUniversity of Queensland research has revealed that having more babies reduces a woman's risk of endometrial cancer.Dr. Gunn-

Updated on: January 23,2024

Having more babies lowers the risk of endometrial cancer, study finds

by Institute for Molecular BioscienceCredit: Unsplash/CC0 Public DomainUniversity of Queensland research has revealed that having more babies reduces a woman's risk of endometrial cancer.Dr. Gunn-

Updated on:January 23,2024

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on: May 09,2024

A smart watch for lymphoedema management

by Astrid Tomczak,ETH ZurichThe Dicronis entrepreneurs Laura Jabinet, Jovan Jancev and Patrizia Marschalkova (from left). Credit: ETH Zürich / Florian BachmannAbout ten percent of all cancer pat

Updated on:May 09,2024